Inspire Investing, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Inspire Investing, LLC

$858 Million
Q4 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$573.97 - $724.32 $546,419 - $689,552	-952 Reduced 49.4%	975 $672,000
Q2 2022 Aug 10, 2022	BUY	$548.35 - $738.84 $49,899 - $67,234	91 Added 4.96%	1,927 $1.14 Million
Q1 2022 Apr 21, 2022	BUY	$595.12 - $698.43 $99,980 - $117,336	168 Added 10.07%	1,836 $1.28 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $676,089 - $834,686	1,244 Added 293.4%	1,668 $1.05 Million
Q4 2021 Feb 03, 2022	SELL	$543.48 - $670.97 $80,978 - $99,974	-149 Reduced 26.0%	424 $268,000
Q3 2021 Nov 09, 2021	SELL	$574.03 - $680.96 $4.12 Million - $4.88 Million	-7,170 Reduced 92.6%	573 $347,000
Q2 2021 Aug 10, 2021	BUY	$472.8 - $558.54 $224,107 - $264,747	474 Added 6.52%	7,743 $4.33 Million
Q1 2021 Apr 30, 2021	BUY	$446.73 - $548.2 $1.03 Million - $1.27 Million	2,308 Added 46.52%	7,269 $3.44 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $460,124 - $584,876	962 Added 24.06%	4,961 $2.4 Million
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $193,386 - $233,664	-355 Reduced 8.15%	3,999 $2.24 Million
Q2 2020 Aug 12, 2020	BUY	$493.32 - $643.92 $680,781 - $888,609	1,380 Added 46.4%	4,354 $2.72 Million
Q1 2020 May 08, 2020	SELL	$336.18 - $494.43 $315,673 - $464,269	-939 Reduced 24.0%	2,974 $1.45 Million
Q4 2019 Jan 24, 2020	BUY	$274.13 - $376.51 $15,351 - $21,084	56 Added 1.45%	3,913 $1.47 Million
Q3 2019 Nov 13, 2019	BUY	$273.46 - $318.39 $59,067 - $68,772	216 Added 5.93%	3,857 $1.07 Million
Q2 2019 Jul 16, 2019	BUY	$299.6 - $414.82 $178,561 - $247,232	596 Added 19.57%	3,641 $1.14 Million
Q1 2019 May 16, 2019	BUY	$372.08 - $439.57 $279,432 - $330,117	751 Added 32.74%	3,045 $1.25 Million
Q4 2018 Feb 22, 2019	BUY	$335.82 - $403.04 $242,797 - $291,397	723 Added 46.02%	2,294 $857,000
Q4 2018 Feb 01, 2019	SELL	$335.82 - $403.04 $180,335 - $216,432	-537 Reduced 25.47%	1,571 $587,000
Q3 2018 Feb 22, 2019	BUY	$351.14 - $408.51 $7,373 - $8,578	21 Added 1.01%	2,108 $852,000
Q3 2018 Nov 07, 2018	BUY	$351.14 - $408.51 $76,548 - $89,055	218 Added 11.66%	2,087 $843,000
Q2 2018 Feb 22, 2019	BUY	$284.6 - $344.99 $245,040 - $297,036	861 Added 85.42%	1,869 $645,000
Q2 2018 Jul 19, 2018	BUY	$284.6 - $344.99 $73,142 - $88,662	257 Added 34.22%	1,008 $348,000
Q1 2018 Feb 22, 2019	BUY	$315.82 - $393.78 $237,180 - $295,728	751 New	751 $259,000
Q1 2018 Apr 13, 2018	SELL	$315.82 - $393.78 $159,804 - $199,252	-506 Closed	0 $0
Q4 2017 Feb 22, 2019	BUY	$358.63 - $469.95 $163,535 - $214,297	456 Added 912.0%	506 $190,000
Q4 2017 Feb 15, 2018	BUY	$358.63 - $469.95 $17,931 - $23,497	50	50 $19,000

Others Institutions Holding REGN

# of Institutions

1,487

Shares Held

84.6M

Call Options Held

1.29M

Put Options Held

1.47M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $71.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.

Account